CJC/IPA w/o DAC
A pairing of two peptides studied for their role in growth hormone signaling. CJC-1295 and Ipamorelin work through complementary mechanisms in research focused on recovery, body composition, and age-related decline.
A pairing studied for how the body changes.
CJC-1295 and Ipamorelin are two of the most-studied peptides in the growth hormone secretagogue family. When paired, they target the same physiological pathway through two different mechanisms — a combination that has made this blend one of the most widely researched approaches in growth hormone modulation.
Growth hormone naturally declines with age, beginning in the late twenties and accelerating through the decades that follow. For women, this decline overlaps with the hormonal shifts of perimenopause, often producing the cluster of symptoms — slower recovery, changes in body composition, sleep disruption — that prompt research into pulsatile GH support.
Published research has documented this peptide pairing’s role in stimulating endogenous growth hormone release, supporting lean tissue maintenance, and improving the depth and architecture of slow-wave sleep. The ‘without DAC’ formulation produces shorter, more pulsatile GH release patterns that more closely mirror the body’s natural rhythms.
Where pulsatile rhythm meets women’s biology.
Body Composition
Sleep Quality
Recovery & Vitality
